Molecular targeted therapy-related life-threatening toxicity in patients with malignancies. A systematic review of published cases

Background Molecular targeted therapy increased overall and disease-free survival in a wide range of malignancies. Although generally well tolerated compared to chemotherapy, molecular targeted therapy may be associated with adverse events requiring ICU admission. Informing clinicians about clinical...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Intensive care medicine Jg. 45; H. 7; S. 988 - 997
Hauptverfasser:	Assoun, Sandra, Lemiale, Virginie, Azoulay, Elie
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Berlin/Heidelberg Springer Berlin Heidelberg 01.07.2019 Springer Springer Nature B.V
Schlagworte:	Adverse events Anesthesiology Angiogenesis Angiogenesis Modulating Agents - adverse effects Antiangiogenic agents Antiangiogenics Antimitotic agents Antineoplastic agents Biomarkers Cancer Cardiovascular Diseases - chemically induced Cardiovascular Diseases - therapy Care and treatment Case reports Chemotherapy Comparative analysis Complications and side effects Critical Care Medicine Drug approval Drug Hypersensitivity - therapy Emergency Medicine Epidermal growth factor receptors ErbB Receptors - antagonists & inhibitors ErbB-2 protein Evidence-based medicine Gastrointestinal Diseases - chemically induced Gastrointestinal Diseases - therapy Health services Humans Hypersensitivity Immune checkpoint inhibitors Immunologic Factors - adverse effects Inhibitors Intensive Intensive care Intensive Care Units Malignancy Medicine Medicine & Public Health Molecular Targeted Therapy - adverse effects Monoclonal antibodies Neoplasms - drug therapy Pain Medicine Patients Pediatrics Pneumology/Respiratory System Receptor, ErbB-2 - antagonists & inhibitors Respiratory Tract Diseases - chemically induced Respiratory Tract Diseases - therapy Review Schedules Severity of Illness Index Side effects Signs and symptoms Systematic review Targeted cancer therapy Toxicity Critical care Molecular targeted therapy Digestive perforation Pneumonitis Malignancies
ISSN:	0342-4642, 1432-1238, 1432-1238
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!